Guide

99213 vs 99214: the MDM line a solo practice can defend

Summary

99214 is justified when at least two of the three MDM elements reach moderate, most often a moderate problem — a chronic illness with an exacerbation, or a new problem with an uncertain course — paired with moderate risk, which is usually prescription drug management. If only one element clears moderate and the rest stay low, the visit is a 99213. Total time in the 30-39 minute range for an established patient supports 99214 on its own, independent of MDM.

By Gale Editorial · Updated 2026-07-26. Every figure cited to a dated source. How we write.

When is 99214 justified instead of 99213?

99214 is justified when the visit's medical decision making reaches moderate on at least two of the three elements — problems, data, and risk — rather than staying low across the board 1Ref 1American Medical Association (2023).CPT evaluation and management (E/M) revisions.That the AMA's 2021 E/M framework sets office-visit levels by medical decision making or total time, with the total-time ranges for established patients — 20-29 minutes for 99213, 30-39 minutes for 99214 — published by the AMA.. The most common real-world pattern is a moderate problem, such as a chronic illness that has flared or an undiagnosed new problem with an uncertain course, combined with moderate risk, usually a decision to start, continue, or adjust a prescription medication.

Without a coder checking every note, the practical test for a solo is simple: name the two elements that would justify the level before submitting the claim, not after. If the note can point to a specific moderate problem and a specific moderate-risk decision, 99214 is defensible. If it can only point to one of the two, the visit is a 99213 no matter how the encounter felt in the room.

The two most common honest paths to 99214

The everyday path is a chronic illness with an exacerbation or progression paired with prescription drug management — refilling a stable medication is not itself the trigger, but adjusting the regimen in response to a worsening condition is 2Ref 2Centers for Medicare & Medicaid Services (2023).Evaluation and Management Services Guide.That medical decision making is scored across the problem, data, and risk elements, that the overall MDM level is set by at least two of the three reaching a given tier, and that prescription drug management is defined as moderate risk.. The second path is a new problem with an uncertain prognosis, which reaches moderate on the problem element by itself even before any medication decision is added, provided it carries a specific current diagnosis, not an unspecified placeholder 3Ref 3Centers for Medicare & Medicaid Services (2026).ICD-10 Codes.That ICD-10-CM is the HIPAA-mandated, annually updated diagnosis code set, so a new problem's uncertain prognosis is documented with a specific current diagnosis rather than a vague one..

Either path only needs to clear moderate on two elements, not high on any of them, which is why 99214 is the workhorse code for a chronic-disease-heavy solo panel rather than an exceptional one. What keeps it honest is that the note names the specific problem and its trajectory, and states the medication decision and the reasoning behind it, rather than defaulting to the higher code because the visit felt substantial.

What keeps a 99213 a 99213

A visit stays at 99213 when the problems addressed are stable and minor — one or more stable chronic illnesses without a flare, or a single acute uncomplicated issue — and the data and risk elements don't independently clear moderate either 1Ref 1American Medical Association (2023).CPT evaluation and management (E/M) revisions.That the AMA's 2021 E/M framework sets office-visit levels by medical decision making or total time, with the total-time ranges for established patients — 20-29 minutes for 99213, 30-39 minutes for 99214 — published by the AMA.. A refill visit for a condition that hasn't changed, with no new data reviewed and no medication adjustment, is the clean example.

The honest failure mode in a solo practice isn't usually inflating a 99213 into a 99214; it's the reverse — a visit that genuinely reached moderate risk through a real medication change gets coded as 99213 out of habit or caution, because the note didn't bother naming the decision. Consistent undercoding across a full panel is a quiet, real loss that never shows up as an error on any single claim.

The documenting mdm habit that makes the level defensible

The habit that protects a solo without a coder is writing the note so the two qualifying elements are visible to a stranger reading it cold: the specific problem and its status, and the specific risk decision with its reasoning. "Continue current meds" documents nothing about risk; "increasing dosage due to inadequate blood pressure control" documents a real, moderate-risk decision.

This matters more in a solo practice than anywhere else, because there is no second set of eyes catching an undercoded or overcoded note before the claim goes out — both directions are the clinician's own risk to manage. A note built to show its own justification, every time, is the difference between a coding pattern that survives a records request and one that has to be reconstructed from memory months later.

Checking your own e/m bell curve

Because there is no coder reviewing claims before they go out, a solo's best internal check is periodically looking at the distribution of levels billed across a full patient panel rather than auditing visit by visit. A pattern skewed heavily toward one level, in either direction, is worth a second look before a payer looks at it first.

This isn't about hitting a target distribution — a panel genuinely made up of stable, simple visits should code low, and a panel of complex chronic disease management should code higher. It's about noticing when the pattern doesn't match the panel, which is usually the first sign that the documentation habit, not the actual clinical complexity, has drifted.

Time as the tie-breaker

When the MDM elements are genuinely borderline, total time offers an independent second path: documented time in the 20-29 minute range for an established patient supports 99213, and 30-39 minutes supports 99214, regardless of which MDM elements were met 1Ref 1American Medical Association (2023).CPT evaluation and management (E/M) revisions.That the AMA's 2021 E/M framework sets office-visit levels by medical decision making or total time, with the total-time ranges for established patients — 20-29 minutes for 99213, 30-39 minutes for 99214 — published by the AMA.. The choice between time or mdm can be made per visit, so a cognitively lighter visit that ran long on counseling can still reach 99214 through time alone.

To use it, the total has to be stated in the note — not estimated afterward from the schedule. A solo who tends to run long visits for genuine reasons, extended counseling or care coordination among them, often finds time is the more reliable path on exactly the visits where MDM feels ambiguous.

A few real patterns, worked

A patient with well-controlled hypertension on an unchanged regimen, no new complaints: one stable chronic illness, no medication change — 99213. The same patient returning with blood pressure trending up and a dose increase: a chronic illness with an exacerbation plus prescription drug management — two moderate elements, 99214.

A new patient complaint that turns out to be self-limited, handled with reassurance and no medication: a single minor problem — 99213, regardless of how much time was spent reassuring the patient, unless that reassurance conversation itself pushed total time past 20 minutes. A patient with two stable chronic conditions who also mentions a new symptom that's genuinely undiagnosed: the new problem alone can reach moderate, and pairing it with any medication decision reaches 99214 even though the other two conditions did nothing to change the level.

Common questions

Not by itself. Continuing a medication with no change and no new problem is low risk and typically pairs with a stable, minor problem — a 99213 pattern. Prescription drug management reaches moderate risk when the regimen is actually being adjusted in response to something, such as inadequate control or a new side effect, not when it's simply being continued unchanged.

Periodically pull the distribution of E/M levels across a full patient panel rather than reviewing individual notes. A pattern that's heavily skewed toward one level, without a clear reason tied to the panel's actual complexity, is the signal worth investigating before a payer's own review flags it.

Yes. Time is an independent path: documented total time of 30-39 minutes on the date of an established-patient visit supports 99214 regardless of the MDM elements, as long as the total is stated in the note. This is useful for visits that ran long on counseling or coordination but weren't cognitively complex.

No. Choosing whichever of MDM or time genuinely supports the higher level, visit by visit, is using the rule as written, not gaming it. Upcoding is billing 99214 when the note can't actually show two moderate elements or a qualifying total time — the distinction is documentation, not which code number came out higher.

One moderate element alone isn't enough; 99214 needs two of the three — problems, data, and risk — at moderate or higher. A visit with moderate data but a low problem and low risk stays at 99213 on MDM, though documented total time in the 30-39 minute range would still support 99214 independently.

Run your practice on Gale

The software is free. Gale earns one flat 3.5% all-in per paid transaction — only on transactions that actually pay. No subscription, no setup fee, no network cut.

Start or manage a practice →

References

1.American Medical Association (2023). CPT evaluation and management (E/M) revisions. American Medical Association (AMA). link ✓That the AMA's 2021 E/M framework sets office-visit levels by medical decision making or total time, with the total-time ranges for established patients — 20-29 minutes for 99213, 30-39 minutes for 99214 — published by the AMA.
2.Centers for Medicare & Medicaid Services (2023). Evaluation and Management Services Guide. CMS Medicare Learning Network (MLN006764). link ✓That medical decision making is scored across the problem, data, and risk elements, that the overall MDM level is set by at least two of the three reaching a given tier, and that prescription drug management is defined as moderate risk.
3.Centers for Medicare & Medicaid Services (2026). ICD-10 Codes. Centers for Medicare & Medicaid Services (CMS). linkThat ICD-10-CM is the HIPAA-mandated, annually updated diagnosis code set, so a new problem's uncertain prognosis is documented with a specific current diagnosis rather than a vague one.

https://www.gale.care/for-providers/em-99213-vs-99214-solo · 3 sources. Competitor details are cited to dated public sources and maintained as they change; figures are estimates, not commitments. Synthetic demonstration.

← Back to for providers